Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-5.35x1.92x0.36x6.21x-3.73x-3.53x-.--% 1.65TCr
20.33x2.41x-4.28x4.71x13.35x14.46x0.49% 8.24TCr
44.98x4.96x4x7.06x22.32x30.56x0.51% 6.32TCr
51.52x6.93x1.23x13.6x29.17x36.53x-.--% 5.49TCr
37.56x2.67x-0.7x3.85x11.13x12.63x2.72% 5.19TCr
16.55x1.42x0.47x3.06x8.89x9.84x-.--% 2.88TCr
15.89x2.74x-21.32x2.61x8.26x7.76x-.--% 2.01TCr
80.69x7.88x-0.05x9.49x99.16x93.54x-.--% 1.98TCr
682.9x3.53x-7.21x5.31x13.58x42.82x-.--% 1.57TCr
-21.88x-7.14x-1.13x31.6x-31.65x-31.23x-.--% 1.45TCr
291.45x57.47x22.95x97.86x178.17x184.28x - 1.42TCr
24.11x - 1.95x3.17x16.27x16x-.--% 1.15TCr
-16.27x - -0.3x585.65x-15.96x-16.18x-.--% 1.1TCr
-47.89x198.62x1.3x14.16x-56.91x-52.73x-.--% 913.53Cr
40.53x - 0.32x19.37x45.57x46.62x-.--% 801.64Cr
17.74x1.18x0.1x2.07x8.59x11.43x1.46% 797.51Cr
5.33x2.07x0.01x2.3x3.42x3.47x3.8% 754.82Cr
-222.12x - 0.68x - - - -.--% 735.06Cr
20.8x1.23x-2.29x - - - 1.28% 596.6Cr
-7.85x1.4x0.02x3.86x-25.79x-26.28x-.--% 585.63Cr
Average 51.45x 18.08x -0.19x 45.33x 17.99x 21.11x 0.54% 2.28TCr
Weighted average by Cap. 54.21x 9.41x -0.56x 24.71x 20.52x 24.17x 0.59%
Biopharmaceuticals